G
Gain Therapeutics (GANX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Gain Therapeutics (GANX)
Gain Therapeutics, Inc. is a biotechnology company. The Company is focused on developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, central nervous system (CNS) disorders, lysosomal storage disord... Read more
- USD1.90
- USD1.94
- USD1.88
- USD3.19
- 1.10%
- --
- 92.59k
- 266.77k
- 53M
- 0.89
- -37.00%
Stock News
3 hours ago
Royal Caribbean boosts profit outlook as record bookings highlight cruise appeal
MarketWatch
3 hours ago
Honeywell shares jump on strong earnings. Here is Jim Cramer's advice on the stock
CNBC
3 hours ago
United Airlines grows highest-end Polaris airport lounge by 50% in battle for wealthy customers
CNBC
4 hours ago
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
